Kodiak Sciences Inc. SEC filings KOD
Kodiak Sciences Inc. has 422 filings in SEC EDGAR's recent list, going back to Jul 28, 2009. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Oct 20, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 28, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 2, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 2, 2026 |
| S-8 | Employee stock plan registration | Mar 31, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Mar 27, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Other events
|
Dec 18, 2025 | Dec 16, 2025 |
| 424B5 | Prospectus supplement | Dec 17, 2025 | — |
| 424B5 | Prospectus supplement | Dec 15, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | Jun 2, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 2, 2025 |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 4, 2024 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 17, 2023 | Aug 16, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 6, 2023 |
| EFFECT | Filing | Jun 2, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| UPLOAD | Letter from the SEC | May 22, 2023 | — |
| EFFECT | Filing | May 17, 2023 | — |
| CORRESP | Letter to the SEC | May 15, 2023 | — |
| S-3 | Shelf registration | May 15, 2023 | — |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| ARS | Annual report to shareholders | Apr 25, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2023 | — |
| DEF 14A | Proxy statement | Apr 25, 2023 | Jun 6, 2023 |
| UPLOAD | Letter from the SEC | Apr 5, 2023 | — |
| S-3 | Shelf registration | Mar 31, 2023 | — |
| S-8 | Employee stock plan registration | Mar 28, 2023 | — |
| 10-K | Annual report | Mar 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Other events
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2022 | Jun 7, 2022 |
| S-8 | Employee stock plan registration | May 10, 2022 | — |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 7, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 23, 2022 | Feb 23, 2022 |
| S-8 | Employee stock plan registration | Dec 15, 2021 | — |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 15, 2021 | Oct 13, 2021 |
| DEFA14A | Additional proxy material | Oct 5, 2021 | — |
| DEF 14A | Proxy statement | Sep 13, 2021 | Oct 13, 2021 |
| PRE 14A | Preliminary proxy statement | Sep 1, 2021 | Sep 30, 2021 |
| DEFA14A | Additional proxy material | Sep 1, 2021 | — |
| 8-K |
Current report
Other events
|
Sep 1, 2021 | Sep 1, 2021 |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 23, 2021 | Jul 21, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2021 | Jun 7, 2021 |
| S-3ASR | Automatic shelf registration | May 10, 2021 | — |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 7, 2021 |
| S-8 | Employee stock plan registration | Mar 2, 2021 | — |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2021 | Mar 1, 2021 |
| 8-K |
Current report
Other events
|
Nov 18, 2020 | Nov 17, 2020 |
| 424B5 | Prospectus supplement | Nov 18, 2020 | — |
| 424B5 | Prospectus supplement | Nov 16, 2020 | — |
| S-3ASR | Automatic shelf registration | Nov 16, 2020 | — |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
New debt
|
Aug 20, 2020 | Aug 14, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Material agreement
|
Jun 25, 2020 | Jun 19, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2020 | Jun 8, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 11, 2020 | May 11, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 8, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2020 | Apr 2, 2020 |
| 10-K | Annual report | Mar 16, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2019 | Dec 17, 2019 |
| 8-K |
Current report
Other events
|
Dec 4, 2019 | Dec 3, 2019 |
| 424B3 | Prospectus | Dec 4, 2019 | — |
| 424B3 | Prospectus | Dec 3, 2019 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 2, 2019 | Dec 1, 2019 |
| 8-K |
Current report
Other events
|
Nov 20, 2019 | Nov 18, 2019 |
| EFFECT | Filing | Nov 14, 2019 | — |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| CORRESP | Letter to the SEC | Nov 12, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2019 | — |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| S-3 | Shelf registration | Nov 1, 2019 | — |
| 8-K |
Current report
Other events
|
Oct 15, 2019 | Oct 11, 2019 |
| 8-K |
Current report
Listing notice
|
Oct 10, 2019 | Oct 4, 2019 |
| 8-K |
Current report
Other events
|
Sep 12, 2019 | Sep 6, 2019 |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2019 | Aug 14, 2019 |
| 8-K |
Current report
Other events
|
Jul 29, 2019 | Jul 27, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2019 | Jun 3, 2019 |
| S-8 | Employee stock plan registration | May 15, 2019 | — |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 15, 2019 | May 15, 2019 |
| DEFA14A | Additional proxy material | Apr 24, 2019 | — |
| DEF 14A | Proxy statement | Apr 24, 2019 | Jun 3, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2019 | Mar 28, 2019 |
| 10-K | Annual report | Mar 27, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 5, 2019 | Jan 30, 2019 |
| 8-K |
Current report
Change to shareholder rights, Other events
|
Jan 28, 2019 | Jan 22, 2019 |
| 10-Q | Quarterly report | Nov 16, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 16, 2018 | Nov 16, 2018 |
| S-8 | Employee stock plan registration | Oct 9, 2018 | — |
| 424B4 | Prospectus | Oct 5, 2018 | — |
| FWP | Free writing prospectus | Oct 4, 2018 | — |
| EFFECT | Filing | Oct 3, 2018 | — |
| CERT | Filing | Oct 2, 2018 | — |
| S-1/A | Amended registration statement | Oct 1, 2018 | — |
| CORRESP | Letter to the SEC | Oct 1, 2018 | — |
| CORRESP | Letter to the SEC | Oct 1, 2018 | — |
| 8-A12B | Filing | Oct 1, 2018 | — |
| CORRESP | Letter to the SEC | Sep 27, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2018 | — |
| CORRESP | Letter to the SEC | Sep 24, 2018 | — |
| S-1/A | Amended registration statement | Sep 24, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2018 | — |
| CORRESP | Letter to the SEC | Sep 14, 2018 | — |
| S-1/A | Amended registration statement | Sep 11, 2018 | — |
| S-1 | Registration statement | Sep 7, 2018 | — |
| UPLOAD | Letter from the SEC | May 11, 2018 | — |
| DRSLTR | Filing | Apr 30, 2018 | — |
| DRS/A | Filing | Apr 30, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2018 | — |
| DRS | Filing | Feb 14, 2018 | — |
| D | Filing | Mar 24, 2016 | — |
| D | Filing | Jul 28, 2009 | — |
Showing 174 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KOD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1468748
- Former names
- Oligasis, LLC (until Jul 28, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.